Why Ascendis CEO is leaving

PUBLISHED: Thu, 01 Mar 2018 15:10:29 GMT
Share

JSE listed Pharmaceutical company, Ascendis Health reported a 27 per cent increase in half year revenue to R4 billion, driven by the strong performance of the group’s international operations which grew revenue by 50 per cent to R1.9 billion.

Sign Up for Our Newsletter Daily Update
Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent.
Get this delivered to your inbox, and more info about about our products and services. By signing up for newsletters, you are agreeing to our Terms of Use and Privacy Policy.